Book 2012

Innate Immune Regulation and Cancer Immunotherapy


ISBN: 978-1-4419-9913-9 (Print) 978-1-4419-9914-6 (Online)

Table of contents (24 chapters)

previous Page of 2
  1. Front Matter

    Pages i-x

  2. Chapter

    Pages 1-5


  3. Chapter

    Pages 7-21

    The Role of NKT Cells in the Immune Regulation of Neoplastic Disease

  4. Chapter

    Pages 23-38

    γδ T Cells in Cancer

  5. Chapter

    Pages 39-49

    Toll-Like Receptors and Their Regulatory Mechanisms

  6. Chapter

    Pages 51-60

    Cytoplasmic Sensing of Viral Double-Stranded RNA and Activation of Innate Immunity by RIG-I-Like Receptors

  7. Chapter

    Pages 61-88

    Innate Immune Signaling and Negative Regulators in Cancer

  8. Chapter

    Pages 89-119

    Dendritic Cell Subsets and Immune Regulation

  9. Chapter

    Pages 121-145

    Human Dendritic Cells in Cancer

  10. Chapter

    Pages 147-173

    Regulatory T Cells in Cancer

  11. Chapter

    Pages 175-193

    Relationship Between Th17 and Regulatory T Cells in the Tumor Environment

  12. Chapter

    Pages 195-216

    Mechanisms and Control of Regulatory T Cells in Cancer

  13. Chapter

    Pages 217-229

    Myeloid-Derived Suppressor Cells in Cancer

  14. Chapter

    Pages 231-250

    Myeloid-Derived Suppressive Cells and Their Regulatory Mechanisms in Cancer

  15. Chapter

    Pages 251-266

    Cell Surface Co-signaling Molecules in the Control of Innate and Adaptive Cancer Immunity

  16. Chapter

    Pages 267-287

    Negative Regulators of NF-κB Activation and Type I Interferon Pathways

  17. Chapter

    Pages 289-301

    Role of TGF-β in Immune Suppression and Inflammation

  18. Chapter

    Pages 303-318

    Indoleamine 2,3-Dioxygenase and Tumor-Induced Immune Suppression

  19. Chapter

    Pages 319-334

    Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives

  20. Chapter

    Pages 335-345

    Human Tumor Antigens Recognized by T Cells and Their Implications for Cancer Immunotherapy

  21. Chapter

    Pages 347-369

    Cancer/Testis Antigens: Potential Targets for Immunotherapy

previous Page of 2